Bavencio Approved for Rare Skin Cancer
THURSDAY, March 23, 2017 -- Bavencio (avelumab) has been approved by the U.S. Food and Drug Administration to treat a rare but aggressive form of skin cancer called Merkel cell carcinoma (MCC), the agency said Thursday in a news release.
The drug,...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Food and Drug Administration (FDA) | General Medicine | Merkel Cell Carcinoma | Skin | Skin Cancer